azacitidine and Blood Poisoning

azacitidine has been researched along with Blood Poisoning in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ades, L; Banos, A; Beve, B; Chait, Y; Chaury, MP; Cheze, S; Cluzeau, T; Dartigeas, C; Delaunay, J; Dombret, H; Dreyfus, F; Fenaux, P; Gardin, C; Guerci, A; Ifrah, N; Isnard, F; Itzykson, R; Marfaing Koka, A; Marolleau, JP; Morel, P; Pautas, C; Plantier, I; Quesnel, B; Raffoux, E; Recher, C; Seegers, V; Stamatoullas, A; Taksin, AL; Thépot, S; Thomas, X; Vey, N1
Barani, B; Dawn, B; Rajasingh, J; Rajasingh, S; Samanta, S; Thangavel, J; Xuan, YT1
Kalayoğlu Beşışık, S; Turan Erkek, E1
Jones, PA; Pillai, AR; Sadik, W; Thachil, J1
Cashen, AF; DiPersio, J; Fisher, N; Shah, AK; Todt, L1

Trials

1 trial(s) available for azacitidine and Blood Poisoning

ArticleYear
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Area Under Curve; Azacitidine; Bone Marrow; Chromatography, High Pressure Liquid; Decitabine; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mass Spectrometry; Middle Aged; Myelodysplastic Syndromes; Sepsis; Tissue Distribution

2008

Other Studies

4 other study(ies) available for azacitidine and Blood Poisoning

ArticleYear
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
    American journal of hematology, 2014, Volume: 89, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cohort Studies; Compassionate Use Trials; Febrile Neutropenia; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Sepsis; Treatment Outcome

2014
Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury.
    Journal of cell science, 2015, Aug-15, Volume: 128, Issue:16

    Topics: Acute Lung Injury; Animals; Azacitidine; Decitabine; Drug Combinations; Endotoxemia; Epigenesis, Genetic; Histone Deacetylases; Humans; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Macrophages; Methyltransferases; Mice; Sepsis; Signal Transduction

2015
An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2016, Mar-05, Volume: 33, Issue:1

    Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Breast Neoplasms; Chemoradiotherapy; Drug Hypersensitivity; Erythema; Fatal Outcome; Female; Humans; Mastectomy, Radical; Sepsis

2016
Interstitial pneumonitis--An important differential diagnosis for pulmonary sepsis in haematology patients.
    Leukemia research, 2012, Volume: 36, Issue:1

    Topics: Aged; Antineoplastic Agents; Azacitidine; Diagnosis, Differential; Female; Hematology; Humans; Lung Diseases, Interstitial; Myelodysplastic Syndromes; Pneumonia; Sepsis

2012